Skip to main content
Novonesis AS logo

Novonesis AS — Investor Relations & Filings

Ticker · NSIS ISIN · DK0060336014 LEI · 529900T6WNZXD2R3JW38 CO Manufacturing
Open in API
Filings indexed 2,308 across all filing types
Latest filing 2024-02-08 Report Publication Anno…
Country DK Denmark
Listing CO NSIS

About Novonesis AS

https://www.novozymes.com/en

Novonesis is a global biosolutions company formed through the combination of Novozymes and Chr. Hansen. The company develops and produces a broad portfolio of biological solutions, including industrial enzymes, functional proteins, and microorganisms such as cultures, probiotics, and yeast. Its products are utilized in over 30 industries to improve efficiency, sustainability, and product quality. Key markets include food and beverage, where solutions enhance nutrition and reduce waste; human and animal health; agriculture, promoting higher crop yields and animal welfare; and household care, for more effective cleaning. Novonesis applies biotechnological principles to address global challenges in production and consumption, aiming to create more sustainable systems and products.

Recent filings

Filing Released Lang Actions
The Novozymes Report 2023
Report Publication Announcement Classification · 100% confidence The document is a short announcement (1302 characters) that explicitly states 'The Novozymes Annual Report 2023 is attached' and provides links to download the actual report files. Following the 'Menu vs Meal' rule, this is an announcement of a report publication rather than the report itself.
2024-02-08 English
Director's Dealing 2024
Director's Dealing Classification · 99% confidence The document explicitly details 'Trading by management and close relations of management' and references Article 19 of the EU Market Abuse Regulation (MAR), which governs insider transactions. This directly corresponds to the definition of Director's Dealing (insider trades by executives). The presence of transaction details (even if summarized, with an attachment for the full details) confirms this classification. It is not a general regulatory filing (RNS) because it fits a more specific category.
2024-02-02 English
Trading by management and close relations of management
Director's Dealing Classification · 100% confidence The document is a formal notification of share transactions by members of the Executive Leadership Team (management) at Novozymes A/S. It explicitly cites the Market Abuse Regulation (EU) No 596/2014, which governs the disclosure of insider/director dealings. The content consists of standardized tables detailing the names, positions, and transaction specifics (shares received via incentive programs) for multiple executives. This aligns perfectly with the definition of 'Director's Dealing' (DIRS).
2024-02-02 English
Declaration of Voting Results & Voting Rights Announcements 2024
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document explicitly states the 'Total number of voting rights and capital on January 31, 2024' following a statutory merger. It details the increase in share capital, the new number of A and B shares, and the total nominal value. This information directly relates to changes in the company's capital structure and share count. This aligns perfectly with the definition of 'Share Issue/Capital Change' (SHA), which covers capital structure changes and new share issuance. Although it mentions a merger (TAR), the core content is the resulting capital structure update, making SHA the most precise fit. It is not a general announcement of a report (RPA/RNS) because it contains the substantive data itself, not just a link to an attachment.
2024-01-31 English
Total number of voting rights and capital on January 31, 2024
Share Issue/Capital Change Classification · 95% confidence The document is an official announcement regarding a change in share capital and total voting rights following a merger. It details the issuance of new shares and the resulting capital structure, which falls under the category of share capital changes and capital structure updates. This is a specific regulatory disclosure required under the Danish Capital Markets Act.
2024-01-31 English
Director's Dealing 2024
Director's Dealing Classification · 99% confidence The document explicitly details 'Trading by management and close relations of management' and cites 'article 19 in Regulation (EU) No 596/2014 on market abuse (the Market Abuse Regulation)'. This regulation mandates disclosures for insider transactions by persons discharging managerial responsibilities (PDMRs). The content includes names, positions, transaction details (Nature of transaction, Price(s) and volume(s), Date of transaction), which are the hallmarks of an insider dealing report. This directly corresponds to the definition of Director's Dealing (DIRS).
2024-01-29 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.